Soluble Neprilysin　― Cardiac Function and Outcome in Hypertrophic Cardiomyopathy ―

Background: Circulating soluble neprilysin (sNEP) predicts outcome in heart failure (HF) patients with reduced ejection fraction (EF), but not in those with preserved EF. We examined sNEP in patients with hypertrophic cardiomyopathy (HCM), and their correlations with other biomarkers, cardiac functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshihisa, Akiomi, Yokokawa, Tetsuro, Ichijo, Yasuhiro, Kimishima, Yusuke, Kanno, Yuki, Misaka, Tomofumi, Sato, Takamasa, Oikawa, Masayoshi, Kobayashi, Atsushi, Yamaki, Takayoshi, Sugimoto, Koichi, Kunii, Hiroyuki, Takeishi, Yasuchika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889477/
https://www.ncbi.nlm.nih.gov/pubmed/33693148
http://dx.doi.org/10.1253/circrep.CR-19-0034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889477/
https://www.ncbi.nlm.nih.gov/pubmed/33693148
http://dx.doi.org/10.1253/circrep.CR-19-0034

Ejemplares similares